Kirsten Gormly

Kirsten Gormly

Adelaide Medical School

Faculty of Health and Medical Sciences

My primary research is focused on gastrointestinal and urological conditions, in particular rectal and prostate cancer.  I am involved in imaging based research as well as collaborations which assess imaging as part of disease assessment and management.  

I also focus on assessing the uptake and use of guidelines for technical quality and reporting in oncological imaging.  Poor image quality reduces the ability to report accurately and failure to use standardised guidelines impedes the ability to compare international research findings accurately. 

Assessing new imaging technologies in oncological and abdominal imaging, such as Dual energy CT, Photon counting CT, high gradient MRI systems and AI assisted MRI sequences is an additional area of research activity. 

 

  • Journals
    Year Citation
    2024 Jain, A., Gormly, K. L., Glyn, T., Sammour, T., Koay, E. J., Oar, A., . . . Vatandoust, S. (2024). Management of rectal cancer in the era of total neoadjuvant therapy and watch and wait: A multidisciplinary team discussion at the Australasian Gastro-Intestinal Trials Group (AGITG) Annual Scientific Meeting 2022. Asia-Pacific Journal of Clinical Oncology, 20(1), 71-80.
    DOI
    2023 Gormly, K. L. (2023). Anal cancer MRI: DWI assists response assessment for squamous cell carcinoma, but achieving widespread high-quality scans remains challenging. European Radiology, 33(11), 7573-7574.
    DOI
    2023 Seah, H. M., Choi, H. C., Bajic, N., Oakden-Rayner, L., & Gormly, K. L. (2023). Assessment of a single-pass venous phase CT chest, abdomen and pelvis and dual-energy CT in general oncology outpatients. Journal of Medical Imaging and Radiation Oncology, 67(4), 349-356.
    DOI Scopus1
    2023 Nougaret, S., Rousset, P., Lambregts, D. M. J., Maas, M., Gormly, K., Lucidarme, O., . . . Hoeffel, C. (2023). MRI restaging of rectal cancer: The RAC (Response–Anal canal–CRM) analysis joint consensus guidelines of the GRERCAR and GRECCAR groups. Diagnostic and Interventional Imaging, 104(7-8), 311-322.
    DOI Scopus1 Europe PMC1
    2022 Vatandoust, S., Wattchow, D., Sposato, L., Michael, M. Z., Leung, J., Gormly, K., . . . Karapetis, C. S. (2022). A longitudinal cohort study of watch and wait in complete clinical responders after chemo-radiotherapy for localised rectal cancer: study protocol. BMC Cancer, 22(1), 13 pages.
    DOI Scopus3 WoS2 Europe PMC1
    2022 Nougaret, S., Rousset, P., Gormly, K., Lucidarme, O., Brunelle, S., Milot, L., . . . Hoeffel, C. (2022). Structured and shared MRI staging lexicon and report of rectal cancer: A consensus proposal by the French Radiology Group (GRERCAR) and Surgical Group (GRECCAR) for rectal cancer. Diagnostic and Interventional Imaging, 103(3), 127-141.
    DOI
    2022 Croft, M., Lim, W., Lavender, N., & Gormly, K. (2022). Optimising CT‐chest protocols and the added value of venous‐phase contrast timing; Observational case‐control. Journal of Medical Imaging and Radiation Oncology, 66(6), 768-775.
    DOI Scopus3 WoS2 Europe PMC1
    2021 Gormly, K. (2021). Rectal MRI: the importance of high resolution T2 technique. Abdominal Radiology, 46(9), 4090-4095.
    DOI Scopus4 WoS4 Europe PMC2
    2021 Gormly, K. L. (2021). High-resolution t2-weighted mri to evaluate rectal cancer: Why variations matter. Korean Journal of Radiology, 22(9), 1475-1480.
    DOI Scopus3 WoS2 Europe PMC3
    2019 Raeside, M., Low, A., Cohen, P., Sutherland, P., & Gormly, K. (2019). Prostate MRI evolution in clinical practice: Audit of tumour detection and staging versus prostatectomy with staged introduction of multiparametric MRI and Prostate Imaging Reporting and Data System v2 reporting. Journal of Medical Imaging and Radiation Oncology, 63(4), 487-494.
    DOI Scopus4 WoS2 Europe PMC2
    2019 Jameson, M. B., Gormly, K., Espinoza, D., Hague, W., Asghari, G., Jeffery, G. M., . . . Ackland, S. P. (2019). SPAR - A randomised, placebo-controlled phase II trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: An AGITG clinical trial. BMC Cancer, 19(1), 12 pages.
    DOI Scopus13 WoS12 Europe PMC8
    2018 Hoffmann, R., Logan, C., O Callaghan, M., Gormly, K., Chan, K., & Foreman, D. (2018). Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?. International Urology and Nephrology, 50(1), 13-19.
    DOI Scopus11 WoS9 Europe PMC8
    2017 Roy, A. C., Wattchow, D., Astill, D., Singh, S., Pendlebury, S., Gormly, K., & Segelov, E. (2017). Uncommon Anal Neoplasms. Surgical Oncology Clinics of North America, 26(1), 143-161.
    DOI
    2016 Gormly, K. L., Coscia, C., Wells, T., Tebbutt, N., Harvey, J. A., Wilson, K., . . . Price, T. (2016). MRI rectal cancer in Australia and New Zealand: an audit from the PETACC-6 trial. Journal of Medical Imaging and Radiation Oncology, 60(5), 607-615.
    DOI Scopus5 WoS4 Europe PMC3
    2016 Raeside, M. C., Gormly, K., Neuhaus, S. J., Kotasek, D., & James, C. (2016). Primary pericardial mesothelioma presenting as multiple pericardial masses on CT. BJR CASE REPORTS, 2(1), 4 pages.
    DOI WoS3 Europe PMC2
    2016 Siddiqui, M. R. S., Gormly, K. L., Bhoday, J., Balyansikova, S., Battersby, N. J., Chand, M., . . . Brown, G. (2016). Interobserver agreement of radiologists assessing the response of rectal cancers to preoperative chemoradiation using the MRI tumour regression grading (mrTRG). Clinical Radiology, 71(9), 854-862.
    DOI Scopus54 WoS49 Europe PMC32
    2015 Gormly, K. L. M., Coscia, C., Wells, T., Tebbutt, N., Harvey, J. A., Wilson, K., . . . Price, T. (2015). MRI rectal cancer in Australia and New Zealand: an audit from the PETACC-6 trial. Cancer Imaging, 15(S1).
    DOI
    2009 Gormly, K. L. M. (2009). Standardised tumour, node and metastasis reporting of oncology CT scans. JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 53(4), 345-352.
    DOI WoS4 Europe PMC2
    2008 Smith, G. E. C., & Gormly, K. L. M. (2008). Magnetic Resonance Imaging in the staging of cervical carcinoma: A pictorial review. Journal of Medical Imaging and Radiation Oncology, 52(5), 427-433.
    DOI Scopus3 WoS3 Europe PMC3
    2004 Gormly, K., & Glastonbury, C. M. (2004). Calcified nodal metastasis from squamous cell carcinoma of the head and neck. Australasian Radiology, 48(2), 240-242.
    DOI
    1996 Gormly, K. L., & Langlois, S. L. P. (1996). Assessment of an online radiology reporting system. Australasian Radiology, 40(4), 408-411.
    DOI

  • Books
    Year Citation
    2006 Neuhaus, S., Devitt, P., & Gormly, K. (Eds.) (2006). Radiology in surgical practice. Churchill Livingstone.

  • Book Chapters
    Year Citation
    2007 Hricak, H., Husband, J., Panicek, D. M., Akin, O., Gormly, K. L., Grewal, R. K., . . . Daniel, E. (2007). Contributors. In Oncologic Imaging (pp. v-viii). Elsevier.
    DOI

  • Conference Papers
    Year Citation
    2021 Gormly, K., Espinoza, D., Hague, W., Jeffrey, M., Price, T., Karapetis, C., . . . Ackland, S. (2021). SPAR: Randomised phase II study of chemoradiation with or without simvastatin as preoperative treatment for rectal cancer (an AGITG trial). In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 17 (pp. 36). WILEY.
    2016 Siddiqui, M. R. S., Bhoday, J., Balyansikova, S., Battersby, N. J., Gormly, K. L., Rao, S., . . . Brown, G. (2016). Inter-observer agreement of radiologists assessing the response of rectal cancers after chemoradiation therapy according to MRI tumour regression grading (mrTRG). In BRITISH JOURNAL OF SURGERY Vol. 103 (pp. 17). Royal Coll Surg England, London, ENGLAND: WILEY-BLACKWELL.

SPAR:  A randomised placebo-controlled phase 2 trial of simvastatin with preoperative chemoradiation for rectal cancer’. M Jameson, S Ackland, M Pearse , S Ngan, F Frizelle, A Stevenson, K Gormly. M Arendse. 2018

  • Health Research Council on NZ (HRC) $NZ 1,399,053
  • Cancer Society New Zealand $NZ 149,290,

RENO: Prospective Study of ‘Watch and Wait’ Strategy in patients with Rectal Cancer who have developed a Clinical Complete Response with concurrent Chemo-radiotherapy.  C Karapetis, D Wattchow, S Vatandoust, L Sposato.  CI. 2018

  • AGITG innovation grant $200,000

 Evaluation of blood-based screening tests for colorectal neoplasia; from biomarker candidates to accurate and acceptable tests. E Symonds, GP Young, M Michael, ..... A Roy,  C Karapetis, K Gormly. 2020

  • AGITG innovation grant $200,000

PETACC 6 Trial: Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer. TJ Price, J Harvey, N Tebbutt, J Zalcberg, J Simes, G Hruby

  • 2013. Cancer Australia + Cancer Council NSW 123,331 + 19,624.  
  • 2009-11. Cancer Australia 477,800

Contributions to the new  BMS / MD Medical Course include;

MS1 & 2 imaging content

MS3 lectures:

  • Imaging in Prostate cancer
  • Imaging in Testicular cancer
  • Imaging in Ovarian Cancer
  • Imaging in Uterine cancer
  • Imaging in Cervix cancer

Planned 4th year MD - face to face session; General Surgical Imaging

Extensive vocational lecturing to radiologists and other medical and allied health groups in national and international forums, including conferences and workshops.

Connect With Me
External Profiles